Proszę używać tego identyfikatora do cytowań lub wstaw link do tej pozycji:
http://hdl.handle.net/11320/18168
Tytuł: | The interferon-induced helicase C domain-containing protein 1 gene variant (rs1990760) as an autoimmune-based pathology susceptibility factor |
Autorzy: | Wawrusiewicz-Kurylonek, Natalia Gościk, Joanna Chorąży, Monika Siewko, Katarzyna Posmyk, Renata Zajkowska, Agata Citko, Anna Maciulewski, Rafał Szelachowska, Małgorzata Myśliwiec, Janusz Jastrzębska, Izabella Kułakowska, Alina Kochanowicz, Jan Krętowski, Adam Jacek |
Słowa kluczowe: | IFIH1 gene Graves’ disease Multiple sclerosis LADA diabetes Polymorphism |
Data wydania: | 2020 |
Data dodania: | 4-kwi-2025 |
Wydawca: | Elsevier |
Źródło: | Immunobiology, Volume 225, Issue 1, 2020, 151864 |
Abstrakt: | Purpose: Autoimmune diseases are a group of complex diseases localized in multiple organ systems, with a wide spectrum of symptoms and still unclear causes. The aim of the present study was to analyse a possible association of three autoimmune disabilities - Multiple sclerosis (MS), LADA diabetes and Graves’ disease (GD) with single nucleotide polymorphism (SNP; rs1990760) in the IF IH1 gene (also known as a melanoma differentiation-associated protein 5 - MDA5) within the Polish population. An additional goal was also to look for a correlation between this polymorphism and different clinical patient-related factors. Materials and methods: The study population consisted of four groups of 944 unrelated Polish origin Caucasian patients – 324 with GD, 171 with MS, 49 with LADA diabetes and 400 healthy subjects as a control group. The SNP analysis was performed using the allelic discrimination technique. Results & Conclusions: There were significant associations of risk T allel of the analyzed polymorphism with all studied autoimmune diseases (GDeOR = 1.34, p = 7.02e-03; MSeOR = 1.36, p = 2.17e-02; LADA – OR = 3.36, p = 8.73e-07). We also found that the frequency of CT and TT genotypes of the rs1990760 IFIH1 gene only in females (with LADA, GD, MS) was significantly higher than those in the female control group (47%, 41% vs 44%, 34%; p = 1.32e-03, p = 4.39e-04; OR = 2.08, 95%CI: (1.33–3.28), OR = 2.29, 95% CI: (1.44–3.65) respectively). Our research has shown significant differences regarding some clinical features (BMI, TRAb, TSH, HbA1C, anti-GAD antibodies) and age at the beginning of the studied autoimmune disabilities. This study showed an association of rs1990760 polymorphism in the IFIH1 gene in the development of GD, LADA diabetes and MS within the Polish population. To our knowledge, this is the first study to investigate the relationship between IFIH1 polymorphisms and the risk of the development of MS and LADA in Poland. |
Afiliacja: | Natalia Wawrusiewicz-Kurylonek - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Joanna Gościk - Faculty of Computer Science Bialystok University of Technology, Wiejska 45A, 15-351 Bialystok, Poland Monika Chorąży - Department of Neurology, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Katarzyna Siewko - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Renata Posmyk - Department of Clinical Genetics, Medical University of Bialystok, Waszyngtona 14, 15-089, Bialystok, Poland Agata Zajkowska - Department of Neurology, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Anna Citko - Clinical Research Centre, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Rafał Maciulewski - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Małgorzata Szelachowska - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Janusz Myśliwiec - Department of Nuclear Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Izabella Jastrzębska - Faculty of Chemistry, University of Bialystok, Ciołkowskiego 1K, 15-245, Białystok, Poland Alina Kułakowska - Department of Neurology, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Jan Kochanowicz - Department of Neurology, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland Adam Jacek Krętowski - Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland; Clinical Research Centre, Medical University of Bialystok, Sklodowska – Curie 24A, 15-276, Bialystok, Poland |
E-mail: | Natalia Wawrusiewicz-Kurylonek: natalia.wawrusiewicz-kurylonek@umb.edu.pl |
URI: | http://hdl.handle.net/11320/18168 |
DOI: | 10.1016/j.imbio.2019.10.013 |
e-ISSN: | 1878-3279 |
Typ Dokumentu: | Article |
metadata.dc.rights.uri: | https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Właściciel praw: | © 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license |
Występuje w kolekcji(ach): | Artykuły naukowe (WChem) |
Pliki w tej pozycji:
Plik | Opis | Rozmiar | Format | |
---|---|---|---|---|
N_Wawrusiewicz_Kurylonek_J_Goscik_I_Jastrzebska_at_al_The_interferon_induced_helicase_C.pdf | 791,27 kB | Adobe PDF | Otwórz |
Pozycja ta dostępna jest na podstawie licencji Licencja Creative Commons CCL